Considering GITR’s pivotal role in regulating immune responses, the modulation of the GITR/GITRL signaling pathway emerges as a promising strategy for fortifying the immune system’s ability to combat and eradicate HCC cells. This evidence concerns the gene TNFRSF18 and hepatocellular carcinoma.